Pluristem Therapeutics Inc (PSTI)

[Melon4head]

Hi HappyBee... Yes watching the metamorphosis has been quite the ride.

I personally am not worried in the slightest over other companies (Celularity) competing in the placental cell market.

Many years ago I represented a company that sold products in the inflammatory market (NSAIDs- Non- steroidal anti-inflammatory).

There were at least 10 if not more direct competitors selling a slightly modified chemical entity that basically had very similar side effects, efficacy and "INDICATIONS". . Our product (Naprosyn) brought 800 million a year- and there were 10 more NSAIDs in the Market.

The reason I highlighted Indications, is that PSTI is in a unique position of patent protection for use of placental cells from a specific location in the placenta- AND the indications for these patents have already been patented.

So when Celularity touts placenta cells and indications DIFFERENT than ours, it only increases public awareness of the miracle of the placenta and it's potential in Healthcare.